Hossein Vahidi Editor

Hamed Barabadi (PharmD, PhD) works as an assistant professor at the Department of Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran. He received a PhD degree from Shahid Beheshti University of Medical Sci-ences, Tehran, Iran, in 2019. He graduated as a Doctor of Pharmacy (PharmD) from Mazandaran University of Medical Sciences, Sari, Iran, in 2014. He owns to his credit a number of research papers, book chapters, and edited books with more than 3000 citations and h-index of 38. He has received many awards such as IET—Nanobiotech¬nology Premium Awards two times continuously in the years 2019 and 2020. Dr. Barabadi has been featured among the World’s Top 2% scientists list, according to a Stanford University study 2020 and 2022. He is the guest editor/editor for various reputed indexed journals such as Current Nanomedicine, Nanoscience and Nanotechnology-Asia, Frontiers in Pharmacology, MDPI International Journal of Molecular Sciences, MDPI Molecules, and a few other prestigious journals. His research interests lie in the area of pharmaceutical nanobiotechnology, ranging from green synthesis, characterization, and optimization of nanobiomaterials to their pharmaceutical potential evaluations, such as anticancer, antimicrobial, antioxidant, etc. Moreover, he has collaborated actively with researchers in several other disciplines of pharmaceutical sciences, particularly the nanoformulation of drugs for drug delivery systems and nanomedicine. Saravanan Muthupandian has over 21 years of teaching and research experience, and he is ranked in the top 2% of scientists worldwide by Stanford University in 2021 and 2022. He is currently working as Professor, AMR and Nanotherapeutics Lab, Department of Pharmacology, Saveetha University, SIMATS, Chennai, India since January 2021. He has graduated in Microbiology from Madurai Kamaraj University and Doctorate with specialization in Medical Microbiology and Nanomedicine from Sathyabama University, India. Thereafter, he worked as a Post-Doctoral Researcher (2011-2012) focusing his research on Nano-biomaterials and their Biomedical Applications. Prior to his postdoc, he worked as an Assistant Professor (SG), SRM University, Department of Biotechnology for six Years, from 2005 to 2011. After his post-doctoral research, he worked as Associate Professor, under the United nation development Program, Department of Medical Microbiology and Immunology, School of Medicine, Mekelle University, Ethiopia until January 2021. His Research specialization is the development of novel biomaterials for emerging and re-emerging Infection, in particular Antimicrobial Resistance (AMR) & Cancer. He has published more than 200 research papers, including high impact journal The Lancet and Nature and Nature Medicine with more than 21000 citations and h-index of 58 and i10 index of 127. He has published Seven books and 35 book chapters. He has participated in more than 100 National and International conferences and Reviewers of more than 100 international peer-reviewed journals, and has been editor for various reputed PubMed and Scopus indexed journals, in particular, he has an Associate editor in Frontiers in Pharmacology, Frontiers in Oncology and MDPI Functional Biomaterials. He has received many fellowships and Awards, notably IET- Nanobiotechnology premium Awards two times continuously in the years 2019 and 2020, International Fellowship “Advanced Course on Diagnostics” Sponsored by LSH&TM & Fondation Mérieux, in France 2013, International Fellowship “Pertussis: biology, epidemiology and prevention” meeting Sponsored by Fondation Mérieux & WHO in France 2014, International Union of Microbiological Societies (IUMS) travel grant in 2015 to Canada, International Fellowship "Advanced Course on Antibiotics” (AdCAb) Sponsored by Institute of Pasteur and Fondation Mérieux France, 2016. Ebrahim Mostafavi has so far received training at Stanford Cardiovascular Institute, Stanford University School of Medicine (PostDoc), Northeastern University (Ph.D.), Harvard Medical School (Researcher), and University of Tehran (M.Sc. and B.Sc.). His research interests revolve around the engineering and development of (nano)biomaterials, nanocarriers, and 3D in vitro models (hydrogels, 3D bioprinted constructs, nanofibrous scaffolds, organoids, vascular grafts, and microfluidic systems) to create biologically complex systems for tissue engineering and regenerative medicine, translational medicine, cancer therapy (with focus on women’s cancer), biosensing, and infectious diseases. Dr. Mostafavi serves as Associate Editor-in-Chief of several prestigious and high-impact journals within Elsevier, Springer, Cell Press, Dove Medical Press, T&F, Frontiers, etc. He is also an Editorial Board Member of 25+ impactful and prestigious biomedical and materials science journals. His scholarly work comprises >145 publications with an H-index of 27 (i10-index= 71) including papers published in The Lancet family and JAMA Network journals. So far, he has edited several books and also contributed to leading more than 40 introductory book chapters in a very multidisciplinary field of biomedical, biotechnology, nanotechnology, and regenerative/translational medicine. Hossein Vahidi (PharmD, PhD) is a Professor and head of the Department of Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Iran. He is currently head of the School of Pharmacy and Director-in-Charge of the Iranian Journal of Pharmaceutical Research (IJPR). His research interests lie in the area of bioprocessing and fermentation of microorganisms for the production of bioactive compounds, optimization of fermentation, and growth of industrial microorganisms.